|
|
 |
Promogen is a biotech company focused on the development
and commercialization of next generation gene expression systems.
Promogen takes full advantage of its advanced technology to
solve the most challenging problems in molecular therapeutics.
|
|
| Promogen’s platform technology involves high throughput
production of synthetic gene promoters. It will allow unprecedented
levels of efficiency and precision in targeted gene expression.
In cancer gene therapy, Promogen’s synthetic Promoters will
help kill cancer cells with the highest efficiency possible,
while leaving normal cells unharmed. |
 |
|
 |
Application of Promogen’s gene expression technology
will be extended into the field of recombinant protein therapeutics.
Tailor made to address the need of each therapeutics manufacturing
facility, Promogen’s synthetic Promoters will maximize protein
production. In this rapidly emerging, but highly competitive
market, companies applying Promogen’s state-of-art technology
will enjoy selective advantage over others. |
|
